Marshall Wace, LLP Retractable Technologies Inc Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.92 - $5.04 $110,138 - $289,114	-57,364 Reduced 47.45%	63,529 $126,000
Q2 2022 Aug 15, 2022	BUY	$3.39 - $4.69 $106,012 - $146,665	31,272 Added 34.89%	120,893 $461,000
Q1 2022 May 16, 2022	SELL	$4.3 - $7.26 $428,903 - $724,148	-99,745 Reduced 52.67%	89,621 $425,000
Q4 2021 Feb 14, 2022	SELL	$6.74 - $10.69 $203,130 - $322,175	-30,138 Reduced 13.73%	189,366 $1.31 Million
Q3 2021 Nov 15, 2021	BUY	$10.3 - $13.45 $526,680 - $687,752	51,134 Added 30.37%	219,504 $2.42 Million
Q2 2021 Aug 13, 2021	BUY	$8.84 - $12.46 $1.49 Million - $2.1 Million	168,370 New	168,370 $1.95 Million
Q1 2021 May 17, 2021	SELL	$11.15 - $21.5 $142,876 - $275,501	-12,814 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.7 - $15.02 $85,853 - $192,466	12,814 New	12,814 $138,000

2.35M

2.7K

100

Ticker RVP
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 32,937,200
Market Cap $20.8M
Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adap...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.